Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying the MYBPC3 missense c.1484G>A mutation

被引：1
|
作者：
Ribeiro, Marta [1 ,2 ]
Martins, Sandra [3 ,4 ]
Carvalho, Teresa [3 ,4 ]
Furtado, Marta [3 ,4 ]
Cabral, Joaquim Sampaio [1 ,2 ]
Brito, Dulce [5 ,6 ]
Carmo-Fonseca, Maria [3 ,4 ]
da Rocha, Simao Teixeira [1 ,2 ]
机构：
[1] Univ Lisbon, Inst Super Tecn, IBB Inst Biosci & Bioengn, Lisbon, Portugal
[2] Univ Lisbon, Inst Super Tecn, Dept Bioengn, Lisbon, Portugal
[3] Univ Lisbon, Associate Lab Inst Hlth & Bioecon i4HB, Inst Super Tecn, Lisbon, Portugal
[4] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal
[5] Ctr Hosp Univ Lisboa Norte, Heart & Vessels Dept, Cardiol Div, Lisbon, Portugal
[6] Univ Lisbon, Ctr Cardiovasc Univ Lisboa CCULRISE, Fac Med, Lisbon, Portugal
来源：
STEM CELL RESEARCH | 2024年 / 74卷
关键词：
D O I：
10.1016/j.scr.2023.103282
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Familial hypertrophic cardiomyopathy (HCM) is the most common inherited heart condition. HCM patients show left ventricle hypertrophy without any associated loading conditions, being at risk for heart failure and sudden cardiac death. Two induced pluripotent stem cell (iPSC) lines were generated from peripheral blood mononuclear cells obtained from two unrelated individuals, a 54-year-old male (F81) and a 44-year-old female (F93), both carrying the MYBPC3 c.1484G>A HCM mutation. iPSCs show expression of pluripotency markers, trilineage differentiation capacity and a normal karyotype. This resource enables further assessment of the pathophysiological development of HCM.
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation
    Qiu, Hangyuan
    Sun, Yaxun
    Pan, Ziwei
    Zhou, Jingjun
    Wang, Hongkun
    Wang, Xiaochen
    Cai, Dongsheng
    Fu, Guosheng
    Gong, Tingyu
    Jiang, Chenyang
    Liang, Ping
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (12):
  • [12] Generation of a human induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient carrying MYH6 /c.611G > A mutation
    Yang, Zongkuai
    Zhou, Jingjun
    Wang, Hao
    Chen, Xianzhen
    Sun, Yaxun
    Jiang, Chenyang
    Liang, Ping
    STEM CELL RESEARCH, 2024, 81
  • [13] Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation
    Mori, Haruka
    Xu, Dongzhu
    Shimoda, Yuzuno
    Yuan, Zixun
    Murakata, Yoshiko
    Xi, Binyang
    Sato, Kimi
    Yamamoto, Masayoshi
    Tajiri, Kazuko
    Ishizu, Tomoko
    Ieda, Masaki
    Murakoshi, Nobuyuki
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [14] Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3
    Dementyeva, E. V.
    Pavlova, S. V.
    Chernyavsky, A. M.
    Zakian, S. M.
    STEM CELL RESEARCH, 2021, 53
  • [15] Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations
    Zhang, Tina Tianbo
    Zhao, Shane Rui
    Alamana, Christina
    Shen, Mengcheng
    Parikh, Victoria
    Wheeler, Matthew T.
    Wu, Joseph C.
    STEM CELL RESEARCH, 2022, 65
  • [16] Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
    Caudal, Arianne
    Mondejar-Parreno, Gema
    Vera, Carlos D.
    Williams, Damon R.
    Shenoy, Sushma P.
    Liang, David
    Wu, Joseph C.
    STEM CELL RESEARCH, 2022, 63
  • [17] Generation of hypertrophic cardiomyopathy specific stem cell lines from a patient who carries myosin binding protein C (MYBPC3) p.Cys1124Leufs*25 mutation
    Jin, J.
    Lu, L.
    Chen, J.
    Weng, G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1609 - 1610
  • [18] Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations
    Cao, Xu
    Jahng, James W. S.
    Lee, Chelsea
    Zha, Yanjun
    Wheeler, Matthew T.
    Sallam, Karim
    Wu, Joseph C.
    STEM CELL RESEARCH, 2021, 55
  • [19] Generation of two induced pluripotent stem cell lines carrying the R14del mutation for ARVD/C
    Vera, Carlos D.
    Manhas, Amit
    Shenoy, Sushma P.
    Wheeler, Matthew T.
    Sallam, Karim
    Wu, Joseph C.
    STEM CELL RESEARCH, 2022, 63
  • [20] Truncating Variants in MYBPC3 Cause Ubiquitin Proteasome System Dysfunction Related to Hypertrophic Cardiomyopathy in Human Induced Pluripotent Stem Cell Model
    Yamamoto, Yuta
    Parikh, Victoria N.
    Ashley, Euan A.
    CIRCULATION, 2022, 146
12345